Literature DB >> 29380440

miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment.

Mateusz Nowicki1, Janusz Szemraj2, Agnieszka Wierzbowska1,3, Małgorzata Misiewicz3, Roman Małachowski1, Agnieszka Pluta1,3, Olga Grzybowska-Izydorczyk1,4, Tadeusz Robak1,3, Anna Szmigielska-Kapłon1,3.   

Abstract

OBJECTIVE: MicroRNAs engaged in angiogenesis and hematopoiesis can influence hematopoietic stem cells (HSCs) homing after transplantation by targeting bone marrow niche microenvironment. This study aimed to examine the kinetics of miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 in autologous HSC transplantation settings.
METHODS: The study comprised of 51 patients with hematological malignancies (42 multiple myeloma, 9 lymphoma). Samples were taken at four time points: before conditioning, after chemotherapy but prior to autologous HSC transplantation (day 0), on day +7, and +14 days after HSCT. The miRNA levels were evaluated by the real-time PCR method.
RESULTS: A significant, steady decline of all tested microRNAs in the course of transplantation, as compared to the baseline, was found. The study revealed that higher levels of miRNA-15a, miRNA-16, miRNA-126, and miRNA-146a on day 0 correlated with longer time to engraftment. Additionally, a positive correlation between the levels of miRNA-15a, miRNA-146a, and miRNA-223 assessed on day +7 and the time to engraftment was observed.
CONCLUSIONS: In conclusion, all investigated microRNAs changed significantly in the course of transplantation. Our results suggest that the miRNAs may participate in hematopoietic recovery in the early post-transplant period and influence engraftment efficiency after HSCT.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  engraftment; hematopoietic stem cells transplantation; lymphoma; miRNA; multiple myeloma

Mesh:

Substances:

Year:  2018        PMID: 29380440     DOI: 10.1111/ejh.13036

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  SIRT1-SIRT7 Expression in Patients with Lymphoproliferative Disorders Undergoing Hematopoietic Stem Cell Mobilization.

Authors:  Mateusz Nowicki; Agnieszka Wierzbowska; Emilia Stec-Martyna; Dominika Kulczycka-Wojdala; Grzegorz Nowicki; Anna Szmigielska-Kapłon
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

2.  Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.

Authors:  Yunhui Xiang; Liuyun Zhang; Pinpin Xiang; Juan Zhang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.